910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) - Concepedia

Concepedia

Publication | Open Access

910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)

DOI Full Paper Access

40

Citations

0

References

2020

Year

Ezra E.W. Cohen, Robert L. Ferris, Amanda Psyrri, Robert I. Haddad, Makoto Tahara, Jean Bourhis, Kevin J. Harrington, P.M-H. Chang, JC Lin, M. Razaq,

Annals of Oncology

No additional data available for this publication yet. Check back later!